World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
74
Citations
24089
World Ranking
1547
National Ranking
35

Pere Domingo publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Pere Domingo sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 570 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Pere Domingo D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Pere Domingo sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 74 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Pere Domingo is affiliated with the Autonomous University of Barcelona in Spain and has a research focus primarily in the field of Medicine, with substantial contributions in Infectious Diseases, Emergency Medicine, Epidemiology, Virology, and Neurology.

Their work spans multiple topics related to infectious and viral diseases, including:

  • HIV-related health complications and treatments
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Pneumocystis jirovecii pneumonia detection and treatment

Pere Domingo has published extensively in peer-reviewed journals with notable frequent publication venues including:

  • Journal of Antimicrobial Chemotherapy
  • Clinical Infectious Diseases
  • The Lancet HIV
  • Open Forum Infectious Diseases
  • SSRN Electronic Journal

Some of their recent papers include:

  • Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19, 2021, JAMA
  • HIV and antiretroviral therapy-related fat alterations, 2020, Nature Reviews Disease Primers
  • The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19), 2020, EBioMedicine
  • Neuropsychological deficits in patients with cognitive complaints after COVID-19, 2022, Brain and Behavior
  • Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms, 2022, Journal of Neurology

Frequent collaborators in their research include:

  • Christoph Stephan
  • Estebán Martínez
  • Adrián Curran
  • Josep M. Llibre
  • Andreu Bruguera

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

    Maria J Buzón;Marta Massanella;Josep M Llibre;Anna Esteve

  • Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

    François Raffi;Hans Jaeger;Eugenia Quiros-Roldan;Helmut Albrecht

  • Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

    Cristina Tural;Lidia Ruiz;Christopher Holtzer;Jonathan Schapiro

  • Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.

    Esteban Martínez;Juan A. Arnaiz;Daniel Podzamczer;David Dalmau

  • Smallpox: The Triumph over the Most Terrible of the Ministers of Death

    Nicolau Barquet;Pere Domingo

  • Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy.

    Pere Domingo;Xavier Matias-Guiu;Ramón M. Pujol;Esther Francia

  • Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study.

    Frank A Post;Graeme J Moyle;Hans Jürgen Stellbrink;Pere Domingo

  • Severe Nucleoside-Associated Lactic Acidosis in Human Immunodeficiency Virus–Infected Patients: Report of 12 Cases and Review of the Literature

    Vicente Falcó;Dolors Rodríguez;Esteban Ribera;Esteban Martínez

  • Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

    L Ruiz;E Negredo;P Domingo;R Paredes

  • Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients

    J M Gallego-Escuredo;J Gómez-Ambrosi;V Catalan;P Domingo

  • HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.

    Marta Giralt;Pere Domingo;Jordi P Guallar;M Luísa Rodríguez de la Concepción

  • Infection caused by Nocardia farcinica: case report and review.

    O. H. Torres;P. Domingo;R. Pericas;P. Boiron

  • Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.

    Joanne Reekie;Csaba Kosa;Frederik Engsig;Antonella d'Arminio Monforte

  • HIV and antiretroviral therapy-related fat alterations.

    John R. Koethe;Claire Lagathu;Jordan E. Lake;Pere Domingo

  • Clinical and microbiological features of nocardiosis 1997-2003.

    J. Muñoz;B. Mirelis;L. M. Aragón;N. Gutiérrez

  • FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss

    Javier Gómez-Ambrosi;Javier Gómez-Ambrosi;José M. Gallego-Escuredo;José M. Gallego-Escuredo;Victoria Catalán;Victoria Catalán;Amaia Rodríguez;Amaia Rodríguez

  • Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

    José R Arribas;Pierre-Marie Girard;Roland Landman;Judit Pich

  • Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated With Highly Active Antiretroviral Therapy

    Juan Berenguer;Pilar Miralles;Julio Arrizabalaga;Esteban Ribera

  • Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection

    Pere Domingo;Olga H Torres;Josep Ris;Guillermo Vazquez

  • Human dendritic cell activities are modulated by the omega-3 fatty acid, docosahexaenoic acid, mainly through PPARγ:RXR heterodimers: comparison with other polyunsaturated fatty acids

    Fernando Zapata‐Gonzalez;Felix Rueda;Jordi Petriz;Pere Domingo

Frequent Co-Authors

Francesc Villarroya
Francesc Villarroya University of Barcelona
Hernando Knobel
Hernando Knobel Autonomous University of Barcelona
Marta Giralt
Marta Giralt University of Barcelona
Eugenia Negredo
Eugenia Negredo University of Vic - Central University of Catalonia
Jose R. Arribas
Jose R. Arribas Hospital Universitario La Paz
José M. Gatell
José M. Gatell University of Barcelona
José M. Miró
José M. Miró University of Barcelona
Antonio Rivero
Antonio Rivero Instituto Maimónides de Investigación Biomédica de Córdoba
Santiago Moreno
Santiago Moreno Hospital Universitario Ramón y Cajal

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various allied health and science careers that combine biology with healthcare and information management. One popular path is becoming a Functional Medicine Nurse Practitioner, where understanding complex biological systems is essential. To learn more about this role and its potential earnings, explore the functional medicine np salary.

For those interested in healthcare administration and coding, becoming a Certified Professional Coder offers promising career opportunities. This role requires precision in medical documentation and billing, essential for efficient healthcare delivery. Detailed information on this career can be found under certified professional coder.

Health Information Management is another growing field that blends technology with healthcare knowledge. Professionals manage sensitive data and contribute to streamlined patient care. If you are considering this route, understanding the healthcare information management salary and job outlook is important.

Many students prefer pursuing their degrees online for flexibility. Programs that are CAHIIM accredited meet high standards for quality education in this sector. To find reputable programs, check out the online cahiim accredited health information management degree options available today.

Best Scientists Citing Pere Domingo

Trending Scientists

Recently Published Articles